In 2023, actual sulphonamide imports to Germany stood at approximately 6.5 million kilograms. From 2024 onwards, forecasts suggest a steady increase from 6.5762 million kilograms, with a year-on-year growth rate of around 1-2%. These increments indicate a moderate but consistent demand expansion. The Compound Annual Growth Rate (CAGR) over this five-year period suggests a sustained yearly increase, emphasizing gradual market stability.
Future trends to monitor include potential changes in Germany's pharmaceutical sector regulations, advancements in medical practices increasing sulphonamide utilization, and economic factors affecting international trade. Monitoring these variables will be crucial for strategic import adjustments.
